Su, David
Kluger, Harriet
Olino, Kelly
Funding for this research was provided by:
NIH Yale Cancer Center Advanced Training Program (T32 CA233414)
Article History
Received: 29 September 2023
Accepted: 25 October 2023
First Online: 21 November 2023
Disclosures
: H.K. discloses institutional research grants (to institution) from Merck, Bristol-Myers Squibb, and Apexigen, and personal fees (past 3 years) from Iovance, Celldex, Merck, Bristol-Myers Squibb, Clinigen, Shionogi, Chemocentryx, Calithera, Signatero, Gigagen, GI reviewers, Seranova, Pliant Therapeutics, and Esai.